Imaging in psoriatic arthritis: established methods and emerging techniques.

135 Another analysis of the MAXIMISE trial identified additional inflammatory and post-inflammatory changes indicative of axPsA and showed a trend toward improved clinical outcomes for patients treated with secukinumab through spinal MRI. 136 Furthermore, the STAR study will prospectively assess efficacy outcomes in PsA patients with MRI-confirmed axial inflammation, aiming at evaluating the ability of guselkumab to reduce both axial symp

also in 53,322 other papers